Patents by Inventor Michael S. Vannieuwenhze

Michael S. Vannieuwenhze has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS FOR IN SITU LABELING OF BACTERIAL CELL WALLS WITH FLUOROPHORES AND METHODS OF USE THEREOF
    Publication number: 20200109430
    Abstract: Disclosed herein are compositions for assessing peptidoglycan biosynthesis in bacteria, for identifying bacteria, and for screening for bacterial cell wall-acting and/or cell wall-disrupting agents via modified D-amino acids and methods of use thereof. Also disclosed are live bacteria having one or more modified D-amino acids as described herein incorporated into peptidoglycan of a bacterial cell wall.
    Type: Application
    Filed: December 6, 2019
    Publication date: April 9, 2020
    Applicant: Indiana University Research and Technology Corporation
    Inventors: Michael S. VanNieuwenhze, Edward Hall, Erkin Kuru, Pamela Brown, Srinivas Tekkam, Velocity Hughes, Yves Brun
  • Compositions for in situ labeling of bacterial cell walls with fluorophores and methods of use thereof
    Patent number: 10544444
    Abstract: Disclosed herein are compositions for assessing peptidoglycan biosynthesis in bacteria, for identifying bacteria, and for screening for bacterial cell wall-acting and/or cell wall-disrupting agents via modified D-amino acids and methods of use thereof. Also disclosed are live bacteria having one or more modified D-amino acids as described herein incorporated into peptidoglycan of a bacterial cell wall.
    Type: Grant
    Filed: July 27, 2018
    Date of Patent: January 28, 2020
    Assignee: Indiana University Research and Technology Corporation
    Inventors: Michael S. VanNieuwenhze, Edward Hall, Erkin Kuru, Pamela Brown, Srinivas Tekkam, Velocity Hughes, Yves Brun
  • Anti-viral compounds
    Patent number: 6087374
    Abstract: The present invention relates to compounds of Formula (I), or a pharmaceutically acceptable salt thereof. These compounds inhibit the growth of piconaviruses, such as rhinoviruses, Hepatitus viruses, cardioviruses, polioviruses, enteroviruses, coxsackieviruses of the A and B groups, echo virus and Mengo virus.
    Type: Grant
    Filed: July 2, 1999
    Date of Patent: July 11, 2000
    Assignee: Eli Lilly and Company
    Inventors: Kurt D. Schladetzky, Wayne A. Spitzer, Michael S. Vannieuwenhze